RDNZ's Submission on rule 8.1b
Rare Disorders NZ has made a submission to Pharmac’s review of rule 8.1b of the Pharmaceutical Schedule
Rare Disorders NZ supports the expansion of rule 8.1b to include all children with serious illnesses, including those with rare disorders and other life-threatening illnesses where there is a medicine available – currently funded or not. Not only life-threatening illnesses but also conditions where early treatment would prevent decline and ill health later in life. Early treatment is essential for long term health and development of children and their future well-being.
Read our final submission here.
Access our submission template here.
Consultation closes at 9am, 27 March 2023.